49 results
424B7
RLAY
Relay Therapeutics Inc
10 Jan 24
Prospectus with selling stockholder info
9:22am
and programs;
developments relating to our competitors and our industry;
the effect of the COVID-19 pandemic, including mitigation efforts and economic effects
424B7
RLAY
Relay Therapeutics Inc
16 Nov 23
Prospectus with selling stockholder info
4:16pm
of laws and regulations on our business and programs;
developments relating to our competitors and our industry;
the effect of the COVID-19 pandemic
8-K
EX-99.1
otxq1sv6
3 Nov 22
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
4:11pm
424B5
icq5qm
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B5
o21hixnf4
12 Sep 22
Prospectus supplement for primary offering
7:35am
424B7
8j2ttrglw3vco7i yy
1 Sep 22
Prospectus with selling stockholder info
4:06pm
8-K
EX-99.1
dvb qwxha4r3jp
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
8-K
EX-99.1
du5dwu
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
zn0k9cesfsjrn5ne7n4u
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
EX-99.2
mgg8il
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
EX-99.1
sg5h 7ti9c3tov
5 May 22
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
12:00am